Search Results

1 - 6 of 6 items :

Clear All
Hyperbaric Oxygen Therapy (HBOT) in Pediatrics

Complications of Treatment Pediatrics 2000, 106(6); 5. http://pediatrics.aappublications.org/content/106/6/e80.full ; 6. Virginia Neubauer, Richard Neubauer and Paul Harch HBOT in the Management of Cerebral Palsy. http://www.hbot.com/blog/infinitee/hyperbaric-oxygen-therapy-management-cerebral-palsy ; 7. McMaster University CanChild Hyperbaric Oxygen Therapy (HBOT) as a ‘treatment’ for Cerebral Palsy https://www.canchild.ca/en/resources/212-hyperbaric-oxygen-therapy-hbot-as-a-treatment-for-cerebral-palsy ; 8. Marek Kawecki, Grzegorz Knefel, Bożena

Open access
Hyperbaric Oxygen Therapy (HBOT) as a Therapeutic Option for Patients with Atopic Dermatitis (AD) – Own Experiences and Literature Review

Abstract

The paper discusses the treatment results of ten patients with severe atopic dermatitis (AD) who did not respond to standard pharmacotherapy and underwent hyperbaric oxygen therapy (HBOT). Each patient was subject to 10 oxygen exposures at pO2 2.5 ATA (~ 250 kPa) with the duration time of 60 minutes. In the period of implementation of the hyperbaric procedures the general treatment plan was suspended for all patients while maintaining typical local treatment. Clinical evaluation was performed in the study group as well as determination of levels of immunoglobulins: IgA, IgG, IgM and IgE and C3 and C4 complement. All patients indicated clinical improvement and a decreased IgE immunoglobulin and complement C3 level upon the completion of the exposure cycle. Taking into account the authors’ own observations and data from literature, an overall improvement in the clinical status and a decrease in the level of immunoglobulin E and C3 complement following a cycle of exposures may be indicative of an immunomodulating HBOT effect on AD, whereas hyperbaric oxygenation may constitute a therapeutic option for some patients with AD, especially those exhibiting a poor response to standard treatment.

Open access
The symptoms of depression and anxiety in patients with diabetic foot treated with hyperbaric oxygen - preliminary results

Abstract

The aim of the study was to assess the level of anxiety and depressiveness in patients who had qualified for hyperbaric oxygen therapy (HBOT) for the treatment of ulcerative lesions in the lower limbs, occurring as a result of diabetic foot syndrome (DFS),. A total of 50 patients with type 2 diabetes and diabetic foot syndrome were enrolled to the study. All patients have received 30 sessions of HBOT. During the therapy blood glucose was measured and photographic documentation was carried out. All patients underwent the following procedures: medical history and socioeconomic interview, psychiatric examination, self-report and objective psychometric tests to measure anxiety and depressiveness. Based on the obtained results, we reported that patients with a greater degree of tissue damage had higher levels of depressive symptoms in the self-report tests as well as in the objective evaluation of the investigator. In terms of location of ulcerative lesions - the level of depressiveness was greater when the affected area included toes, and the level of anxiety was increased when it concerned the heel. Regarding other parameters, statistically significant correlations were not observed.

Open access
The effect of hyperbaric oxygen therapy on the nervous system. Systematic review

Abstract

Hyperbaric oxygen therapy (HBOT) is found among the interests of researchers who seek new methods of treatment of diseases of the nervous system. An increase of the partial pressure of oxygen in arterial blood within the appropriate range leads to numerous changes in the cells of the brain tissue. In this paper we analyse the results of selected articles describing HBOT used on pathologies of the nervous system such as stroke, autism, multiple sclerosis and cerebral palsy as well as in the course of research on animal models. The results are promising, although some studies struggled with numerous methodological problems and differences in the applied protocols, which resulted in conflicting results in individual interventions. In consequence, the need for further studies in randomised control trials and determination of the protocol by an international group of researchers dedicated to the use of HBOT was emphasised.

Open access
Adverse reactions of hyperbaric oxygen therapy - case description of a generalised seizure

Abstract

Hyperbaric oxygen therapy (HBOT) is a safe treatment, provided fulfilling certain rules of patient qualifications to treatment, as well as supervision over the course of therapy by qualified medical staff. Side effects reported in the literature are rare, and are usually mild and transient. Professional medical staff allows minimising the adverse events occurrence. The scale of complications is unknown, especially in Polish hyperbaric center. Careful analysis could be used to develop prevention procedures for patients of hyperbaric oxygen therapy. Hyperbaric Oxygen Centre and Wound Treatment in Bydgoszcz during 28 months performed hyperbaric oxygen therapy (HBOT) in case of 423 patients. During this period, adverse events occurred occasionally. 17 cases have been reported. Authors described study case 77 year-old patient who was admitted due to non-healing wound-left lower abdomen (state after radiotherapy). During the fourth session, on decompression phase patient have had a generalized seizure (tonic-clonic). The decompression was stopped, the oxygen supply was disconnected but only after the drug administration seizures terminated. The most likely causative agent of the adverse reactions of the patient treated with HBOT was the oxygen toxic effect on the brain tissue. However, analyzing the circumstances of the seizure termination: phase of decompression at the pressure 2ATA and lack of oxygen disconnection response, it cannot be excluded other causes of this complication.

Open access
Influence of hyperbaric oxygenation and its use in urinary tract diseases

pomocą hiperbarycznej terapii tlenowej na rok 2013. J Res Health Sci 2013; 3 (9):125-134 Polish[The guidelines of the European Society of Hyperbaric Medicine, the Society of Underwater and Hyperbaric Medicine and the National Health Fund Polish Republic on a hyperbaric oxygen therapy (HBOT) in 2013]; 4. Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97: 385-395; 5. Hincu M, Petcu LC, Mehedinti R, Mehedinti T. Correlated histological and morphometric study of kidney and adrenal gland from Guinea pig exposed to

Open access